107 related articles for article (PubMed ID: 16826618)
1. New tests for Alzheimer's disease.
Health News; 2006 Jun; 12(6):2. PubMed ID: 16826618
[No Abstract] [Full Text] [Related]
2. New tests for AD.
Health News; 2006 Apr; 12(4):15. PubMed ID: 16578901
[No Abstract] [Full Text] [Related]
3. To tap or not to tap: cerebrospinal fluid biomarkers of Alzheimer's disease.
Growdon JH
Ann Neurol; 1998 Jul; 44(1):6-7. PubMed ID: 9667586
[No Abstract] [Full Text] [Related]
4. [Biological markers for diagnosis of Alzheimer's disease].
Takeda M; Tanaka T; Kudo T; Okochi M; Kamino A; Tagami S
Seishin Shinkeigaku Zasshi; 2004; 106(12):1610-4. PubMed ID: 15770965
[No Abstract] [Full Text] [Related]
5. Cerebrospinal fluid biomarkers in Alzheimer's disease: are the hypotheses more dynamic than the biomarkers?
Spies PE; Verbeek MM; Olde Rikkert MG; Claassen JA
J Am Geriatr Soc; 2010 Aug; 58(8):1619-20. PubMed ID: 20942893
[No Abstract] [Full Text] [Related]
6. Alzheimer's biomarker initiative hits its stride.
Miller G
Science; 2009 Oct; 326(5951):386-9. PubMed ID: 19833956
[No Abstract] [Full Text] [Related]
7. The diagnosis of Alzheimer disease before it is Alzheimer dementia.
Frisoni GB; Padovani A; Wahlund LO
Arch Neurol; 2003 Jul; 60(7):1023; author reply 1023-4. PubMed ID: 12873864
[No Abstract] [Full Text] [Related]
8. [Biological marker for Alzheimer's disease].
Matsubara E
Brain Nerve; 2010 Jul; 62(7):769-75. PubMed ID: 20675881
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease.
Skogseth R; Mulugeta E; Jones E; Ballard C; Rongve A; Nore S; Alves G; Aarsland D
Dement Geriatr Cogn Disord; 2008; 25(6):559-63. PubMed ID: 18536520
[TBL] [Abstract][Full Text] [Related]
10. [Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease].
Smach MA; Charfeddine B; Lammouchi T; Dridi H; Ben Othman L; Bennamou S; Limem K
Ann Biol Clin (Paris); 2008; 66(5):531-5. PubMed ID: 18957342
[TBL] [Abstract][Full Text] [Related]
11. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease.
Engelborghs S; Sleegers K; Cras P; Brouwers N; Serneels S; De Leenheir E; Martin JJ; Vanmechelen E; Van Broeckhoven C; De Deyn PP
Brain; 2007 Sep; 130(Pt 9):2320-6. PubMed ID: 17586559
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.
Gerhardsson L; Blennow K; Lundh T; Londos E; Minthon L
Dement Geriatr Cogn Disord; 2009; 28(1):88-94. PubMed ID: 19672066
[TBL] [Abstract][Full Text] [Related]
13. Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1-42).
Kaiser E; Schönknecht P; Thomann PA; Hunt A; Schröder J
Neurosci Lett; 2007 May; 417(2):193-5. PubMed ID: 17408854
[TBL] [Abstract][Full Text] [Related]
14. Biological markers in cerebrospinal fluid (CSF) and evaluation of in vitro effect of CSF on PC12 cell line viability in Alzheimer's disease.
Yaka E; Egrilmez MY; Keskinoglu P; Cavdar Z; Genc S; Genc K; Iyilikci L; Yener GG
Cell Biochem Funct; 2009 Aug; 27(6):395-401. PubMed ID: 19639578
[TBL] [Abstract][Full Text] [Related]
15. [Biomarkers in cerebrospinal fluid and blood in memory complaints].
Zetterberg H; Andreasen N; Blennow K
Lakartidningen; 2009 May 13-19; 106(20):1386-9. PubMed ID: 19585836
[No Abstract] [Full Text] [Related]
16. Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease.
Taniguchi M; Okayama Y; Hashimoto Y; Kitaura M; Jimbo D; Wakutani Y; Wada-Isoe K; Nakashima K; Akatsu H; Furukawa K; Arai H; Urakami K
Dement Geriatr Cogn Disord; 2008; 26(2):117-22. PubMed ID: 18654083
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical dementia diagnostics: State of the art and research perspectives.
Lewczuk P; Wiltfang J
Proteomics; 2008 Mar; 8(6):1292-301. PubMed ID: 18271068
[TBL] [Abstract][Full Text] [Related]
18. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal stability of CSF biomarkers in Alzheimer's disease.
Blennow K; Zetterberg H; Minthon L; Lannfelt L; Strid S; Annas P; Basun H; Andreasen N
Neurosci Lett; 2007 May; 419(1):18-22. PubMed ID: 17482358
[TBL] [Abstract][Full Text] [Related]
20. No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease.
Buerger K; Alafuzoff I; Ewers M; Pirttilä T; Zinkowski R; Hampel H
Brain; 2007 Oct; 130(Pt 10):e82. PubMed ID: 17615094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
